Medicare program; changes to Medicare payment for drugs and physician fee schedule payments for calendar year 2004....

Area of Science:

• Health Policy
• Medical Economics
• Pharmaceutical Policy

Background:

• The Medicare Prescription Drug, Improvement, and Modernization Act (MPDIMA) of 2003 mandates changes to Medicare payment systems.
• Existing payment methodologies for certain Part B drugs and physician services required revision for 2004.

Purpose of the Study:

• To implement 2004 provisions of MPDIMA concerning Medicare payments.
• To update payment rules for Part B drugs, biologicals, and physician fee schedule services.
• To extend opt-out provisions to additional healthcare providers.

Main Methods:

• Interim final rule implementation of MPDIMA provisions.
• Revision of payment methodology for non-cost or prospective payment Part B drugs and biologicals.
• Adjustment of geographic practice cost indices and physician fee schedule conversion factors.

Main Results:

• Established the 2004 physician fee schedule conversion factor at $37.3374.
• Set the 2004 national anesthesia conversion factor at $17.4969 (pre-geographic adjustment).
• Superseded conflicting information from the November 7, 2003 final rule regarding physician fee schedule payments.

Conclusions:

• The rule finalizes key payment adjustments for Medicare Part B drugs and physician services for 2004.
• Opt-out provisions are extended to dentists, podiatrists, and optometrists, enhancing provider flexibility.
• This update ensures alignment with the legislative intent of MPDIMA for improved Medicare coverage and administration.